217 related articles for article (PubMed ID: 12219638)
1. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
Krüger K
Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
[No Abstract] [Full Text] [Related]
2. [Efficacy of leflunomide].
Hirohata S
Nihon Rinsho; 2002 Dec; 60(12):2357-63. PubMed ID: 12510362
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
Singer O; Gibofsky A
Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy: where are we now?
Resman-Targoff BH
Am J Health Syst Pharm; 2006 Sep; 63(18 Suppl 4):S11-8. PubMed ID: 16960243
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials.
Golicki D; Newada M; Lis J; Pol K; Hermanowski T; Tłustochowicz M
Pol Arch Med Wewn; 2012; 122(1-2):22-32. PubMed ID: 22353705
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
Mroczkowski PJ; Weinblatt ME; Kremer JM
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M
Transplant Proc; 1998 Dec; 30(8):4135-6. PubMed ID: 9865325
[No Abstract] [Full Text] [Related]
9. Leflunomide in the treatment of rheumatoid arthritis.
Li EK; Tam LS; Tomlinson B
Clin Ther; 2004 Apr; 26(4):447-59. PubMed ID: 15189743
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide improves quality of life in rheumatoid arthritis.
Scott DL
Scand J Rheumatol Suppl; 1999; 112():23-9. PubMed ID: 10668524
[TBL] [Abstract][Full Text] [Related]
11. Disease modification in rheumatoid arthritis with leflunomide.
Emery P
Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
[TBL] [Abstract][Full Text] [Related]
12. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Kremer JM
Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
[TBL] [Abstract][Full Text] [Related]
13. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with leflunomide in rheumatoid arthritis].
Krüger K; Bolten W
Z Rheumatol; 2005 Mar; 64(2):96-101. PubMed ID: 15793675
[No Abstract] [Full Text] [Related]
15. Progress in the treatment of rheumatoid arthritis.
Pisetsky DS; St Clair EW
JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
[No Abstract] [Full Text] [Related]
16. [Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis].
Shevchuk SV; Stanislavchuk MA; Pentiuk OO
Lik Sprava; 2003; (3-4):34-41. PubMed ID: 12889354
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
Lee SW; Park HJ; Kim BK; Han KH; Lee SK; Kim SU; Park YB
Arthritis Res Ther; 2012 Oct; 14(5):R232. PubMed ID: 23107811
[TBL] [Abstract][Full Text] [Related]
18. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database.
Scott DL; Strand V
Rheumatology (Oxford); 2002 Aug; 41(8):899-909. PubMed ID: 12154207
[TBL] [Abstract][Full Text] [Related]
19. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Strand V; Scott DL; Emery P; Kalden JR; Smolen JS; Cannon GW; Tugwell P; Crawford B;
J Rheumatol; 2005 Apr; 32(4):590-601. PubMed ID: 15801012
[TBL] [Abstract][Full Text] [Related]
20. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]